
Francine K Welty MD
Preventive Cardiology, Cardiovascular Disease Genetics
Associate Professor of Medicine, Harvard Medical School, Cardiologist, Beth Israel Deaconess Medical Center
Join to View Full Profile
Beth Israel Deaconess Medical Center185 Pilgrim Rd. Deac 1Boston, MA 02215
Phone+1 617-667-6010
Fax+1 617-667-6020
Dr. Welty is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Beth Israel Deaconess Medical CenterFellowship, Cardiovascular Disease, 1988 - 1991
- Sidney Kimmel Medical College at Thomas Jefferson University/Christiana Care Health ServicesResidency, Internal Medicine, 1986 - 1988
- Tufts Medical CenterResidency, Orthopaedic Surgery, 1985 - 1986
- Beth Israel Deaconess Medical CenterResidency, Surgery, 1983 - 1985
- Johns Hopkins UniversityInternship, Internal Medicine, 1981 - 1982
- Case Western Reserve University School of MedicineClass of 1981
Certifications & Licensure
- MA State Medical License 1984 - 2025
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Mechanisms of Low Levels of Apolipoprotein B Start of enrollment: 1997 Aug 01
- Targeting Inflammation Using Salsalate in CardioVascular Disease Start of enrollment: 2008 Sep 01
- Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids Start of enrollment: 2009 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- The Data Monitoring Experience in Empagliflozin Randomized Clinical Trials Between 2011 and 2024.Francine K Welty, Klaus G Parhofer, Marvin Konstam, Michael K Palmer, Barry Greenberg
Therapeutic Innovation & Regulatory Science. 2025-02-26 - The Effect of Eicosapentaenoic and Docosahexaenoic Acid Supplementation on Coronary Artery Calcium Progression in Subjects With Diabetes and Coronary Artery Disease: A...Abdul Aziz Asbeutah, Ralph Daher, Abdulaziz Malik, Essa Hariri, Abdulhamied Alfaddagh
The American Journal of Cardiology. 2024-08-15 - 1 citationsHigher epicardial adipose tissue volume is associated with higher coronary fatty plaque volume and is regulated by waist circumference but not EPA+DHA supplementation.Maral Amangurbanova, Ralph Daher, Abdul Aziz Asbeutah, Bhavya Vemuri, Hasan Mirza
Journal of Clinical Lipidology. 2024-07-05
Authored Content
- Management of Stable Coronary Artery Disease in Patients with Diabetes MellitusAugust 2020
- Management of Stable Coronary Artery Disease in Patients with Diabetes MellitusAugust 2020
Press Mentions
- Culture, Diet, Economic Factors and More Affect CVD Risk Among Asian AmericansMay 8th, 2023
- AHA News: Two Omega-3s in Fish Oil May Boost Brain Function in People with Heart DiseaseNovember 9th, 2021
- Both Statins and Placebos Produce ‘Very Real’ Side Effects: SAMSONNovember 15th, 2020
- Join now to see all
Grant Support
- Periodontal Disease And Coronary Artery Remodeling In CHD And Metabolic SyndromeNational Institute Of Dental &Craniofacial Research2007–2011
- Weight Loss, Inflammation, And Vascular RemodelingNational Heart, Lung, And Blood Institute2006–2011
- Metabolic Syndrome, Inflammation And Vascular RemodelingNational Heart, Lung, And Blood Institute2006–2011
- Core--Database &StatisticsNational Heart, Lung, And Blood Institute2006–2011
- AdministrativeNational Heart, Lung, And Blood Institute2006
- APOB And APOA-I Kinetics In The Apob-67 MutationNational Heart, Lung, And Blood Institute2002–2006
- Mechanisms Of Low Levels Of Apolipoprotein BNational Center For Research Resources2005
- Teaching Nutrition To Prevent Cardiovascular DiseasesNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2004
- Mechanisms Of Low Levels Of Apolipoprotein BNational Heart, Lung, And Blood Institute2000
- Mechanisms Of Low Levels Of Apolipoprotein BNational Heart, Lung, And Blood Institute1997–1999
- Apolipoprotein B Mutations And MetabolismNational Heart, Lung, And Blood Institute1994–1995
- Apolipoprotein B Mutations And Lipoprotein MetabolismNational Heart, Lung, And Blood Institute1991–1993
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: